Global Blood Therapeutics, Inc (GBT) Covered Calls

You can sell covered calls on Global Blood Therapeutics, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for GBT (prices last updated Fri 4:16 PM ET):

Global Blood Therapeutics, Inc (GBT) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
58.57 -2.22 40.00 61.25 723K -13.7 3.4B
Covered Calls For Global Blood Therapeutics, Inc (GBT)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Jun 21 60 3.00 58.25 3.0% 30.4%
Sep 20 60 5.50 55.75 7.6% 21.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Global Blood Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics to treat grievous blood-based disorders. Its lead product candidate is voxelotor, an oral once-daily therapy that modulates hemoglobin's affinity for oxygen, which is in Phase III clinical trials in adult and adolescent patients with sickle cell disease (SCD). The company is also involved in evaluating the safety and pharmacokinetics of single and multiple doses of voxelotor in a Phase IIa clinical trials of adolescent and pediatric patients with SCD; and other research and development activities that are in pre-clinical phase. Global Blood Therapeutics, Inc. was founded in 2011 and is headquartered in South San Francisco, California.